Literature DB >> 32006068

Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.

S Mogadas1, C-J Busch2, C Pflug3, H Hanken4, A Krüll1, C Petersen1, S Tribius5.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients with oropharyngeal carcinoma (OPC) often have difficulty swallowing, which may affect quality of life (QoL). Radiation dose to constrictor muscles plays an important role.
METHODS: 54 patients with locally advanced OPC were evaluated after intensity-modulated radiotherapy. Data were collected at standardized intervals using the EORTC questionnaires QLQ-C30 and QLQ-HN35 within two years. The pharyngeal constrictors (superior, middle, and inferior) were each contoured as an organ at risk. Influence of dose to the constrictors (≥55 Gy vs. <55 Gy) on late dysphagia and QoL was analyzed using the t‑test.
RESULTS: Late radiation-induced dysphagia depends significantly on the dose to the lower pharyngeal constrictor. At a dose of ≥55 Gy, 14 (64%) patients developed dysphagia grade ≤2 and 8 (36%) patients grade ≥3. At a dose of <55 Gy, the distribution at the end of radiotherapy (RT) was similar: 22 (69%) patients with dysphagia grade ≤2, 10 (31%) with grade ≥3. There was no dose-dependent difference in the severity of dysphagia in the acute phase (p = 0.989). There were differences 18 months after the end of RT: ≥55 Gy: 19 (86%) patients showed dysphagia grade ≤2; 3 (14%) grade ≥3. At <55 Gy, 31 (97%) patients developed grade ≤2, 1 (3%) grade ≥3 (18 months: p = 0.001; 24 months: p = 0.000). Late dysphagia is also dependent on the dose level of the middle constrictor muscle (6 months: p = 0.000; 12 months: p = 0.005, 18 months: p = 0.034). After 24 months, there was no significant difference (p = 0.374).
CONCLUSION: Radiation dose to the upper constrictor muscle appears to be of little relevance. The middle and lower constrictor should be given special consideration to avoid late dysphagia. Long-term QoL is independent on radiation dose.

Entities:  

Keywords:  Dose effect; Head and neck cancer; Intensity-modulated radiation therapy; Late toxicity; Long-term study

Year:  2020        PMID: 32006068     DOI: 10.1007/s00066-019-01572-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Authors:  Silke Tribius; Sven Haladyn; Henning Hanken; Chia-Jung Busch; Andreas Krüll; Cordula Petersen; Corinna Bergelt
Journal:  Strahlenther Onkol       Date:  2020-12-30       Impact factor: 3.621

2.  F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.

Authors:  M Hecht; S Semrau; M Beck; J Hartwich; M Eckstein; D Schmidt; A O Gostian; S Müller; S Rutzner; U S Gaipl; J von der Grün; T Illmer; M G Hautmann; G Klautke; J Döscher; T Brunner; B Tamaskovics; A Hartmann; H Iro; T Kuwert; R Fietkau
Journal:  Ann Nucl Med       Date:  2022-05-10       Impact factor: 2.258

3.  Incorporating dose-volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy.

Authors:  Stefano Ursino; Alessia Giuliano; Fabio Di Martino; Paola Cocuzza; Alessandro Molinari; Antonio Stefanelli; Patrizia Giusti; Giacomo Aringhieri; Riccardo Morganti; Emanuele Neri; Claudio Traino; Fabiola Paiar
Journal:  Strahlenther Onkol       Date:  2020-10-09       Impact factor: 3.621

4.  Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1).

Authors:  Masahiro Inada; Yasumasa Nishimura; Satoshi Ishikura; Kazuki Ishikawa; Naoya Murakami; Takeshi Kodaira; Yoshinori Ito; Kazuhiko Tsuchiya; Yuji Murakami; Junichi Saito; Tetsuo Akimoto; Kensei Nakata; Michio Yoshimura; Teruki Teshima; Takashi Toshiyasu; Yosuke Ota; Toshiyuki Minemura; Hidetoshi Shimizu; Masahiro Hiraoka
Journal:  Radiat Oncol       Date:  2022-07-28       Impact factor: 4.309

5.  Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer.

Authors:  Michael Beck; Sabine Semrau; Marlen Haderlein; Antoniu-Oreste Gostian; Julius Hartwich; Sarina Müller; Annett Kallies; Carol-Immanuel Geppert; Miriam Schonath; Florian Putz; Udo Gaipl; Benjamin Frey; Marc Saake; Heinrich Iro; Michael Uder; Arndt Hartmann; Torsten Kuwert; Rainer Fietkau; Markus Eckstein; Markus Hecht
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

6.  Comparison of Functional and Survival Outcomes in Pedicled and Microsurgical Flap Reconstruction for Near-Total and Total Glossectomies.

Authors:  Elroy Saldanha; Dhruv G Patel; Sanjay M Desai; Vinod Dhakad; Bonny Joseph; Sandeep Ghosh; Ashma Monteiro
Journal:  Ann Maxillofac Surg       Date:  2022-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.